DB03 Pill - yellow round, 6mm
Pill with imprint DB03 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by APP Pharmaceuticals, LLC.
Letrozole is used in the treatment of Breast Cancer, Adjuvant; Breast Cancer, Metastatic; Breast Cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for DB03
Letrozole
- Imprint
- DB03
- Strength
- 2.5 mg
- Color
- Yellow
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Aromatase inhibitors, Hormones/antineoplastics
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- APP Pharmaceuticals, LLC
- National Drug Code (NDC)
- 63323-0772 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
hypromelloses,
lactose monohydrate,
magnesium stearate,
corn starch,
microcrystalline cellulose,
polyethylene glycol,
sodium starch glycolate type A potato,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
More about letrozole
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (357)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: aromatase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
